Annals of Thoracic and Cardiovascular Surgery · 2017 · 27 citations · 17 references
MedicineCardiologyPharmacotherapyAndrologyCardiovascular PharmacotherapyMen's HealthCardiovascular DiseaseCoronary Artery DiseaseCoronary Artery SurgeryErectile DysfunctionSexual DysfunctionSide EffectsBeta-adrenergic Blocker UseBeta-blocker Use
PURPOSE: Beta-blocker use is common in the cases with coronary artery bypass surgery. According to the literature, beta-blockers have positive effects but may cause erectile dysfunction (ED). The most commonly used beta-blockers in ischemic cardiac disease are nebivolol and metoprolol. In our clinic, we aimed to compare the effects of nebivolol and metoprolol succinate on ED in the sexually active cases with coronary artery bypass surgery. METHODS: In our clinic, a total of 119 patients with coronary artery bypass surgery were included in the study. International Index of Erectile Function (IIEF-5) Test was used to evaluate whether the patients had ED and to grade the cases. RESULTS: No significant difference was found in terms of anti-ischemic efficacy between metoprolol succinate and nebivolol in the postoperative period; however, the incidence of any grade ED was %85.96 in Group 1, %83.87 in Group 2. This difference was considered as statistically significant (p = 0.036). CONCLUSION: Beta-blocker use increases the risk of ED in cases with ischemic cardiac disease. We suggest that the complaints of ED could be less frequent with nebivolol use in sexually active cases with ischemic cardiac disease.
17
2007 Guidelines for the Management of Arterial Hypertension
Giuseppe Mancia, Guy De Backer, Anna F. Dominiczak et al. · Journal of Hypertension · 2007 · 5.8K citations
2013 ESH/ESC Guidelines for the management of arterial hypertension
Giuseppe Mancia, Robert Fagard, Krzysztof Narkiewicz et al. · Journal of Hypertension · 2013 · 5.7K citations
NIH Consensus Conference. Impotence. NIH Consensus Development Panel on Impotence
JAMA · 1993 · 843 citations